Schwanomma histology diagram and key points pathology

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Loading Image
Loading Image
I now have all the content and images needed. Let me compile the comprehensive answer.

Schwannoma - Histology & Pathology

Histology Diagrams

From Robbins & Kumar Pathologic Basis of Disease (Cotran, Fig. 27.14):
Schwannoma - Antoni A and Antoni B areas with Verocay bodies (Robbins Cotran)
(A) Dense eosinophilic Antoni A area (left) vs loose pale Antoni B area (right), with hyalinized blood vessels (arrow). (B) High-power view of the Antoni A area showing nuclear palisading rows forming Verocay bodies (anuclear zones between palisading nuclei).

From Robbins & Kumar Basic Pathology (Fig. 20.6), with Verocay body highlighted:
Schwannoma Antoni A and B areas with Verocay body circled (Basic Pathology)
(A) Low-power: densely cellular Antoni A (left) + loose hypocellular Antoni B (right) + hyalinized vessels. (B) Circled area = a single Verocay body - two palisading rows of nuclei flanking a nuclear-free zone.

From Fitzpatrick's Dermatology (Fig. 121-22B) - Verocay bodies in focus:
Schwannoma Verocay bodies - Fitzpatrick's Dermatology
Nuclear palisades surrounding aggregates of cytoplasmic processes = Verocay bodies.

Key Pathology Points

Origin & Definition

  • Benign tumor arising from Schwann cells of the peripheral nerve sheath
  • Also called neurilemmoma or neurilemoma
  • Tumor cells express S-100 protein and SOX10 - key IHC markers
  • Surrounded by continuous basement membrane (visible on EM or IHC)

Gross Pathology

  • Well-circumscribed, encapsulated mass (fibrous capsule = epineurium + residual nerve fibers)
  • Attaches loosely to the nerve but does not invade it - grows eccentrically, displacing nerve fascicles
  • Firm, gray/tan-yellow; may be cystic when >3-4 cm
  • No axons are detectable within the tumor (unlike neurofibromas)

Microscopic Hallmarks (H&E)

FeatureDescription
Antoni A areasHypercellular; compact spindle-shaped Schwann cells in short bundles or interlacing fascicles; nuclei elongated, twisted, wavy/"buckled"
Antoni B areasHypocellular; cells loosely arranged in myxoid matrix; irregular cystic spaces; thick-walled hyalinized blood vessels
Verocay bodiesPathognomonic - two parallel rows of palisading nuclei separated by anuclear zones of stacked cytoplasmic processes (found in Antoni A areas)
Blood vesselsThick-walled, hyalinized - characteristic finding
AxonsAbsent (excluded from tumor)

Immunohistochemistry

MarkerResult
S-100Strongly and diffusely positive (nuclear + cytoplasmic)
SOX10Positive
EMANegative (helps distinguish from perineurioma)
CD34Variable
NeurofilamentNegative (no axons)

Special Subtypes

SubtypeFeatures
Ancient schwannomaLong-standing tumor with marked degenerative changes, nuclear atypia (large hyperchromatic nuclei), but NO mitoses - behaves benignly
Cellular schwannomaHypercellular, predominantly Antoni A, lacks Antoni B areas - can mimic sarcoma; still benign
Plexiform schwannomaMultiple lobules along nerve; associated with NF2 or schwannomatosis (rare intradermal type)
Melanotic psammomatous schwannomaAssociated with Carney syndrome (spotty pigmentation + myxomas + endocrine overactivity)

Degenerative Changes (especially in Antoni B)

  • Hyalinization
  • Cyst formation
  • Hemorrhage
  • Fibrosis
  • Calcification
  • Xanthomatous change
These are degenerative, not malignant features.

Genetics

  • Sporadic schwannomas: somatic inactivating mutations in NF2 gene (chr 22q12)
  • NF2 (Neurofibromatosis type 2): autosomal dominant; bilateral vestibular schwannomas are hallmark; NF2 gene product = merlin (cytoskeletal protein; regulates cell shape, growth, adhesion)
  • Schwannomatosis: rare familial syndrome with multiple schwannomas without bilateral vestibular schwannomas

MRI Correlates (mirroring histology)

  • Predominantly Antoni A component → intermediate signal on T1 and T2
  • Predominantly Antoni B component → hyperintense on T2 (loose myxoid stroma)
  • "Split fat sign": rim of fat on T1
  • "Target sign": low T2 centrally + high T2 peripherally (in ~50% of cases) - suggests benign diagnosis
  • Fusiform mass along a nerve course

Key Differentials

TumorDistinguishing Features
NeurofibromaContains axons, no capsule, no Verocay bodies, wavy collagen "carrot shavings," NF1 association; malignant transformation possible
MPNSTHigh mitoses, necrosis, nuclear pleomorphism, loss of S-100
LeiomyomaSMA/desmin positive, no S-100
Solitary fibrous tumorCD34+, STAT6+, patternless architecture
FibrosarcomaHerringbone pattern, mitoses, no S-100

Sources: Robbins, Cotran & Kumar - Pathologic Basis of Disease (Fig. 27.14) | Robbins & Kumar - Basic Pathology (Fig. 20.6) | Fitzpatrick's Dermatology Vol. 1-2 (Fig. 121-22) | Campbell's Operative Orthopaedics 15e | Cummings Otolaryngology Head & Neck Surgery
This is a shared conversation. Sign in to Orris to start your own chat.